Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

This study found that using body hair along with scalp hair in hair transplantation can significantly increase visual density and improve coverage in patients with higher grades of androgenetic alopecia.

Warts in HIV-positive men can have serious abnormal cell growth, needing careful analysis and treatment to prevent cancer.

This study found that female pattern hair loss was common in postmenopausal women, with body mass index being a significant associated factor.

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

The document explains how hair loss patterns in men and women, known as Androgenetic alopecia, are classified using the Hamilton-Norwood system for men and the Ludwig grade system for women.

This study found that men with androgenic alopecia had significantly different hair copper levels compared to controls, but no difference in blood copper levels between the groups was observed.

This study found that weekly low-dose bicalutamide was safe and appeared to be associated with high-grade PIN remission and favorable PSA modulation in subjects with persistently elevated PSA but negative biopsy.

This article discusses patterned androgenic alopecia in normal women and reports no new clinical findings.

This study found that women with female pattern hair loss exhibited hormonal imbalances, with the Free Androgen Index being a particularly effective diagnostic marker.

In this study, a 26-year-old woman with polycystic ovarian disease and advanced hair loss (Ludwig Grade III) showed reduced hair shedding and improved hair density after four sessions of platelet-rich plasma combined with microneedling, with no reported adverse effects.

In this study, a 26-year-old woman with polycystic ovarian disease and severe hair loss showed reduced hair shedding and improved hair density following four sessions of platelet-rich plasma combined with microneedling, with no adverse effects reported.

This retrospective cohort study found that both spironolactone and bicalutamide significantly improved Sinclair grade in women with female pattern hair loss over 24 months, but spironolactone, especially at doses above 100 mg/day, resulted in greater efficacy, required less monitoring, and maintained comparable safety.

This case report highlights the growing trend of adolescents using Finasteride off-label for early hair loss, driven by online misinformation and psychological distress, despite potential side effects and hormonal concerns.

This narrative review reports that tissue-engineered scaffolds for wound healing generally match standard care outcomes, with some trials indicating faster healing and improved scar quality, despite challenges like limited cellular infiltration and inadequate vascularization.

This study found that among male and female patients at a dermatology clinic, higher severity of androgenetic alopecia was statistically associated with lower sexual function scores, although the findings should be interpreted cautiously due to sample size and methodological limitations.

This study found that 49% of female breast cancer patients treated with CDK4/6 inhibitors for at least three months developed alopecia, which significantly impacted their quality of life, with greater alopecia severity leading to worse emotional and functional well-being.

This study examined the clinical patterns and trichoscopic features of female pattern hair loss at a rural tertiary care hospital, but it does not report any specific results.

Systemic minoxidil improves hair density in women with female pattern hair loss over time.

This study found that platelet-rich plasma therapy significantly increased hair diameter and density in male androgenetic alopecia patients over six months, particularly in those with AGA durations up to five years.

This study found that 5% azelaic acid solution and 2% minoxidil solution both significantly increased hair density and shaft diameter in women with FPHL, with no significant differences between them.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

This study found that while female pattern hair loss in young to middle-aged women was commonly associated with markers of hyperandrogenism and specific histopathological features, its exact causes and treatment remain unclear.

The robotic system for hair restoration surgery works well, giving similar results to manual techniques after 9 months.

This study found that one year of finasteride treatment significantly reduced PSA levels and prostate volume in men with elevated PSA and negative prior biopsy, potentially aiding prostate cancer diagnosis.

The document concludes that accurately identifying leukemia types is crucial, and the risks of cancer from finasteride need careful evaluation against its benefits.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

This review discusses the paradoxical effects of valproic acid on hair, noting that it can both cause alopecia and stimulate hair growth, but reports no new experimental findings.

This study reported that multiple factors including genetics and psychological influences are related to androgenetic alopecia, and finasteride showed a 77.8% response rate after three months of treatment.

This article discusses Propecia in dermatology but provides no new research findings.